Itraconazole
14 NDCs across 11 manufacturers|12 Generic,2 Brand
Itraconazole is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, oral candidiasis and vulvovaginal candidiasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 11, 1992, and the first generic was approved May 28, 2004. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Itraconazole across 38,000 claims for 16,000 beneficiaries.
Itraconazole is available as 14 NDCs from 11 manufacturers (12 generic, 2 brand), with NADAC prices from $0.90 to $28.36 per EA — the most expensive product costs about 31× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
12G / 2B
Manufacturers
11
competing in market
Price Spread
$0.90 – $28.36
per EA, 12 of 14 NDCs
7d Activity
avg +7.2% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
11 manufacturers producing ITRACONAZOLE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SPORANOX 100 MG CAPSULE | $28.3568 per EA | — |
SPORANOX 100 MG CAPSULE | $28.3568 per EA | — |
ITRACONAZOLE 10 MG/ML SOLUTION | $1.1253 per ML | +1.02% |
ITRACONAZOLE 10 MG/ML SOLUTION | $1.1253 per ML | +1.02% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
ITRACONAZOLE 100 MG CAPSULE | $0.9029 per EA | +8.39% |
Frequently Asked Questions
What is Itraconazole used to treat?
Itraconazole is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, oral candidiasis and vulvovaginal candidiasis, per the National Library of Medicine's MED-RT classification.
When did Itraconazole become available as a generic?
FDA approved the first generic Itraconazole (ANDA) on May 28, 2004. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Itraconazole?
In 2024, Medicare Part D spent $8 million on Itraconazole across 38,000 claims for 16,000 beneficiaries.
How many Itraconazole products are on the market?
The Itraconazole drug market contains 14 NDCs from 11 manufacturers — 12 generic and 2 brand products.
What is the price range for Itraconazole?
NADAC reference prices for Itraconazole range from $0.9029 to $28.3568 per EA — the most expensive product costs about 31× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Itraconazole cheaper than brand?
The average generic NADAC for Itraconazole is $0.9029 per EA, versus $28.3568 for brand-labeled products — brand versions average about 31× the generic price.
Which manufacturers make Itraconazole?
11 manufacturers list Itraconazole in NADAC. Ranked by number of NDCs, the largest are Janssen Pharmaceuticals Inc. (2), Amneal Pharmaceuticals LLC (2), Alembic Pharmaceuticals Inc. (2), Camber Pharmaceuticals Inc. (1), AvPAK (1).
How has the price of Itraconazole changed recently?
Over the past 7 days, 12 Itraconazole NDCs rose and 0 fell, with a market-wide average change of +7.2%.